Vizora日本語

Morishita JintanMORISHITA JINTAN CO.,LTD.4524東証スタンダード医薬品FY ending Mar 2026, consolidated, J-GAAP

Morishita Jintan FY ending Mar 2023 results

About 74% of Morishita Jintan's sales come from Healthcare business division, with Capsule contract manufacturing business division and Other making up much of the rest.

Out of every ¥100 of sales, about ¥5 is left as operating profit.

Revenue changed +18.8% from the prior year, operating profit +90.3%.

Revenue and profit pattern

Revenue and profit upProfit grew faster

Revenue +18.8% · profit +90.3%, calculated from disclosed figures.

Operating leverage: 4.81× (profit growth ÷ revenue growth)

What changed from last year

FY ending Mar 2022 → FY ending Mar 2023

Revenue
+18.8%¥9.56B → ¥11.4B
Gross profit
+8.9%¥4.88B → ¥5.31B
Operating income
+90.3%¥299M → ¥569M
Net income attributable to owners
+73.5%¥283M → ¥491M
Operating cash flow
+117.1%¥543M → ¥1.18B
Free cash flow
Back to profit-¥159M → ¥715M

Where the money goes

FY ending Mar 2022 → FY ending Mar 2023

Where ¥100 of sales goes

For every ¥100 Morishita Jintan sells, how much goes where, and how much is kept.

FY ending Mar 2023
Cost of sales
¥53
SG&A
¥42
Operating profit
¥5
Net profit kept
¥4

Annual margin trends

Gross margin46.8%
FY ending Mar 2020: 53.0%53.0%FY ending Mar 2021: 50.8%50.8%FY ending Mar 2022: 51.0%51.0%FY ending Mar 2023: 46.8%46.8%FY20FY21FY22FY23
Operating margin5.0%
FY ending Mar 2020: 4.6%4.6%FY ending Mar 2021: 2.4%2.4%FY ending Mar 2022: 3.1%3.1%FY ending Mar 2023: 5.0%5.0%FY20FY21FY22FY23
Net margin4.3%
FY ending Mar 2020: 3.3%3.3%FY ending Mar 2021: 2.2%2.2%FY ending Mar 2022: 3.0%3.0%FY ending Mar 2023: 4.3%4.3%FY20FY21FY22FY23

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Mar 2023
  • Healthcare business division¥8.39B
    74%
    Op. margin -1.8%
  • Capsule contract manufacturing business division¥2.96B
    26%
    Op. margin 24.1%
  • Other¥5M
    0%
    Op. margin 100.0%

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (6)

  • EDINET (FSA Japan)

    有価証券報告書－第89期(2025/04/01－2026/03/31)

    ID S100YE3I2026-06-22Open

  • EDINET (FSA Japan)

    有価証券報告書－第88期(2024/04/01－2025/03/31)

    ID S100W0BR2025-06-20Open

  • EDINET (FSA Japan)

    有価証券報告書－第87期(2023/04/01－2024/03/31)

    ID S100TRZ72024-06-26Open

  • EDINET (FSA Japan)

    有価証券報告書－第86期(2022/04/01－2023/03/31)

    ID S100R8RC2023-06-29Open

  • EDINET (FSA Japan)

    有価証券報告書－第85期(令和3年4月1日－令和4年3月31日)

    ID S100OJ6V2022-06-29Open

  • EDINET (FSA Japan)

    有価証券報告書－第84期(令和2年4月1日－令和3年3月31日)

    ID S100LOVX2021-06-29Open

Extracted from XBRL: 47 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image